top of page

A new study by ImmunoBiome-POSTECH research team identifies new drug candidate targeting multiple sclerosis and inflammatory bowel disease

Microbiome Times

A new study by ImmunoBiome-POSTECH research team identifies new drug candidate targeting multiple sclerosis and inflammatory bowel disease

ImmunoBiome Inc.

Tel.  054-279-4429        |

e-mail  contact@immunobiome.co.kr    | 

Registration No.  610-87-01336

#2101, Bio Open Innovation Center, 47 Jigok-ro, Nam-gu, Pohang City, North Gyeongsang Province

  • 링크드 인
bottom of page